Literature DB >> 25681341

TRAF4-SMURF2-mediated DAZAP2 degradation is critical for IL-25 signaling and allergic airway inflammation.

Jarod A Zepp1, Ling Wu2, Wen Qian3, Wenjun Ouyang4, Mark Aronica5, Serpil Erzurum5, Xiaoxia Li6.   

Abstract

IL-25 promotes type 2 immunity by inducing the expression of Th2-associated cytokines. Although it is known that the IL-25R (IL-17RB) recruits the adaptor protein ACT1, the IL-25R signaling mechanism remains poorly understood. While screening for IL-25R components, we found that IL-25 responses were impaired in Traf4 (-/-) cells. Administering IL-25 to Traf4 (-/-) mice resulted in blunted airway eosinophilia and Th2 cytokine production. Notably, IL-25R recruitment of TRAF4 was required for the ACT1/IL-25R interaction. Mechanistically, TRAF4 recruited the E3-ligase SMURF2, to degrade the IL-25R-inhibitory molecule DAZAP2. Silencing Dazap2 increased ACT1/IL-25R interaction and IL-25 responsiveness. Moreover, a tyrosine within the IL-25R elicited DAZAP2 interference. This study indicates that TRAF4-SMURF2-mediated DAZAP2 degradation is a crucial initiating event for the IL-25 response.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25681341      PMCID: PMC4366881          DOI: 10.4049/jimmunol.1402647

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs.

Authors:  H Shiels; X Li; P T Schumacker; E Maltepe; P A Padrid; A Sperling; C B Thompson; T Lindsten
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo.

Authors:  M M Fort; J Cheung; D Yen; J Li; S M Zurawski; S Lo; S Menon; T Clifford; B Hunte; R Lesley; T Muchamuel; S D Hurst; G Zurawski; M W Leach; D M Gorman; D M Rennick
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

3.  Cutting edge: interleukin 17 signals through a heteromeric receptor complex.

Authors:  Dean Toy; David Kugler; Martin Wolfson; Tim Vanden Bos; Jesse Gurgel; Jonathan Derry; Joel Tocker; Jacques Peschon
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production.

Authors:  Mee Rhan Kim; Raffi Manoukian; Richard Yeh; Scott M Silbiger; Dimitry M Danilenko; Sheila Scully; Jilin Sun; Margaret L DeRose; Marina Stolina; David Chang; Gwyneth Y Van; Kristie Clarkin; Hung Q Nguyen; Yan Bin Yu; Shuqian Jing; Giorgio Senaldi; Gary Elliott; Eugene S Medlock
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 6.  The STIR-domain superfamily in signal transduction, development and immunity.

Authors:  Maria Novatchkova; Andreas Leibbrandt; Johannes Werzowa; Annette Neubüser; Frank Eisenhaber
Journal:  Trends Biochem Sci       Date:  2003-05       Impact factor: 13.807

7.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Authors:  Susumu Nakae; Yutaka Komiyama; Aya Nambu; Katsuko Sudo; Michiko Iwase; Ikuo Homma; Kenji Sekikawa; Masahide Asano; Yoichiro Iwakura
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

Review 8.  Interleukin-17 family and IL-17 receptors.

Authors:  T A Moseley; D R Haudenschild; L Rose; A H Reddi
Journal:  Cytokine Growth Factor Rev       Date:  2003-04       Impact factor: 7.638

9.  Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction.

Authors:  R Schwandner; K Yamaguchi; Z Cao
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  The structure, expression and function prediction of DAZAP2, a down-regulated gene in multiple myeloma.

Authors:  Yiwu Shi; Saiqun Luo; Jianbin Peng; Chenghan Huang; Daren Tan; Weixin Hu
Journal:  Genomics Proteomics Bioinformatics       Date:  2004-02       Impact factor: 7.691

View more
  16 in total

Review 1.  Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Authors:  Leticia Monin; Sarah L Gaffen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity.

Authors:  Xinyang Song; Xiao He; Xiaoxia Li; Youcun Qian
Journal:  Cell Mol Immunol       Date:  2016-03-28       Impact factor: 11.530

3.  Deleted in azoospermia-associated protein 2 regulates innate immunity by stimulating Hippo signaling in crab.

Authors:  Lei Yang; Xuejie Li; Xiang Qin; Qiying Wang; Kaimin Zhou; Hao Li; Xin Zhang; Qun Wang; Weiwei Li
Journal:  J Biol Chem       Date:  2019-08-08       Impact factor: 5.157

4.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

5.  SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis.

Authors:  Mengjun Ma; Wen Yang; Zhaopeng Cai; Peng Wang; Hongyu Li; Rujia Mi; Yuhang Jiang; Zhongyu Xie; Pengfei Sui; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells       Date:  2021-02-06       Impact factor: 6.277

6.  The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.

Authors:  Aleksandra Górska; Marta Gruchała-Niedoszytko; Marek Niedoszytko; Agnieszka Maciejewska; Marta Chełmińska; Marcin Skrzypski; Bartosz Wasąg; Małgorzata Kaczkan; Magdalena Lange; Bogusław Nedoszytko; Ryszard Pawłowski; Sylwia Małgorzewicz; Ewa Jassem
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-04-16       Impact factor: 4.291

7.  TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.

Authors:  EunGi Kim; Wanyeon Kim; Sungmin Lee; Jahyun Chun; JiHoon Kang; Gaeul Park; IkJoon Han; Hee Jung Yang; HyeSook Youn; BuHyun Youn
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

8.  TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2.

Authors:  Jinteng Li; Peng Wang; Zhongyu Xie; Shan Wang; Shuizhong Cen; Ming Li; Wenjie Liu; Su'an Tang; Guiwen Ye; Guan Zheng; Hongjun Su; Mengjun Ma; Xiaohua Wu; Yanfeng Wu; Huiyong Shen
Journal:  Cell Death Differ       Date:  2019-05-10       Impact factor: 15.828

Review 9.  TRAF Regulation of IL-17 Cytokine Signaling.

Authors:  Shadi Swaidani; Caini Liu; Junjie Zhao; Katarzyna Bulek; Xiaoxia Li
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 8.786

Review 10.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.